摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(哌啶-3-氧基)苯甲腈 | 902836-93-5

中文名称
3-(哌啶-3-氧基)苯甲腈
中文别名
3-(3-哌啶氧基)苯甲腈
英文名称
3-(Piperidin-3-yloxy)benzonitrile
英文别名
3-piperidin-3-yloxybenzonitrile
3-(哌啶-3-氧基)苯甲腈化学式
CAS
902836-93-5
化学式
C12H14N2O
mdl
——
分子量
202.25
InChiKey
OSURJDMYHKQISX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    342.5±37.0 °C(Predicted)
  • 密度:
    1.13±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    45
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 危险等级:
    6.1
  • 海关编码:
    2933399090
  • 包装等级:
    III
  • 危险类别:
    6.1

SDS

SDS:88912c6e5e2940a51afd1c1b863dc1d2
查看

文献信息

  • [EN] SUBSTITUTED CARBAMATE COMPOUNDS AND THEIR USE AS TRANSIENT RECEPTOR POTENTIAL (TRP) CHANNEL ANTAGONISTS<br/>[FR] COMPOSÉS CARBAMATE SUBSTITUÉS ET LEUR UTILISATION EN TANT QU'ANTAGONISTES DU CANAL POTENTIEL RÉCEPTEUR TRANSITOIRE (TRP)
    申请人:HOFFMANN LA ROCHE
    公开号:WO2014060341A1
    公开(公告)日:2014-04-24
    The invention is concerned with the compounds of formula (I): and pharmaceutically acceptable salts thereof, wherein Y, R1 and R3 are defined in the detailed description and claims. In addition, the present invention relates to methods of manufacturing and using the compounds of formula (I) as well as pharmaceutical compositions containing such compounds. The compounds of formula (I) are antagonists of the TRPA1 channel and may be useful in treating inflammatory diseases and disorders associated with that channel.
    该发明涉及式(I)的化合物及其药学上可接受的盐,其中Y、R1和R3在详细描述和权利要求中有定义。此外,本发明涉及制备和使用式(I)的化合物的方法,以及含有这些化合物的药物组合物。式(I)的化合物是TRPA1通道的拮抗剂,可能对治疗与该通道相关的炎症性疾病和紊乱有用。
  • Inhibitors of Ion Channels
    申请人:Marron Brian Edward
    公开号:US20130072471A1
    公开(公告)日:2013-03-21
    Compounds, compositions and methods are provided which are useful in the treatment of diseases through the inhibition of sodium ion flux through voltage-gated sodium channels. More particularly, the invention provides substituted aryl sulfonamides, compositions comprising these compounds, as well as methods of using these compounds or compositions in the treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels associated with the onset or recurrence of the indicated conditions. The compounds, compositions and methods of the present invention are of particular use for treating neuropathic or inflammatory pain by the inhibition of ion flux through a voltage-gated sodium channel.
    本发明提供了在通过抑制电压门控钠通道中的钠离子流来治疗疾病方面有用的化合物、组合物和方法。更具体地,本发明提供了取代芳基磺酰胺、包含这些化合物的组合物,以及使用这些化合物或组合物治疗中枢或外周神经系统疾病,特别是疼痛和慢性疼痛的方法,通过阻断与所示条件的发生或复发相关的钠通道来实现。本发明的化合物、组合物和方法特别适用于通过抑制电压门控钠通道中的离子流来治疗神经病性或炎症性疼痛。
  • SUBSTITUTED CARBAMATE COMPOUNDS
    申请人:HOFFMANN-LA ROCHE INC
    公开号:US20150218141A1
    公开(公告)日:2015-08-06
    The invention is concerned with the compounds of formula (I): and pharmaceutically acceptable salts thereof, wherein Y, R1 and R3 are defined in the detailed description and claims. In addition, the present invention relates to methods of manufacturing and using the compounds of formula (I) as well as pharmaceutical compositions containing such compounds. The compounds of formula (I) are antagonists of the TRPA1 channel and may be useful in treating inflammatory diseases and disorders associated with that channel.
    本发明涉及式(I)的化合物及其药学上可接受的盐,其中Y、R1和R3在详细说明和权利要求中有定义。此外,本发明还涉及制造和使用式(I)化合物的方法,以及含有这些化合物的制药组合物。式(I)化合物是TRPA1通道的拮抗剂,可能有助于治疗与该通道相关的炎症性疾病和障碍。
  • INHIBITORS OF ION CHANNELS
    申请人:Marron Brian Edward
    公开号:US20090143358A1
    公开(公告)日:2009-06-04
    Compounds, compositions and methods are provided which are useful in the treatment of diseases through the inhibition of sodium ion flux through voltage-gated sodium channels. More particularly, the invention provides substituted aryl sulfonamides, compositions comprising these compounds, as well as methods of using these compounds or compositions in the treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels associated with the onset or recurrence of the indicated conditions. The compounds, compositions and methods of the present invention are of particular use for treating neuropathic or inflammatory pain by the inhibition of ion flux through a voltage-gated sodium channel.
    本发明提供了化合物、组合物和方法,通过抑制电压门控钠通道中的钠离子流来治疗疾病。更具体地,本发明提供了取代芳基磺酰胺、包含这些化合物的组合物,以及使用这些化合物或组合物治疗中枢或外周神经系统疾病,特别是疼痛和慢性疼痛的方法,通过阻止与所示疾病的发生或复发有关的钠通道。本发明的化合物、组合物和方法特别适用于通过抑制电压门控钠通道中的离子流来治疗神经病理性或炎症性疼痛。
  • EP1995241A1
    申请人:——
    公开号:EP1995241A1
    公开(公告)日:2008-11-26
查看更多